Mesenchymal (Stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and …
N Eiro, M Fraile, A González-Jubete… - International journal of …, 2022 - mdpi.com
Inflammatory bowel diseases (IBD) are an example of chronic diseases affecting 40% of the
population, which involved tissue damage and an inflammatory process not satisfactorily …
population, which involved tissue damage and an inflammatory process not satisfactorily …
Stem cell therapy in inflammatory bowel disease: a review of achievements and challenges
CM Tian, Y Zhang, MF Yang, HM Xu… - Journal of …, 2023 - Taylor & Francis
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis
(UC), is a group of chronic inflammatory diseases of the gastrointestinal tract. Repeated …
(UC), is a group of chronic inflammatory diseases of the gastrointestinal tract. Repeated …
Freezing biological organisms for biomedical applications
G Kuang, Q Zhang, J Jia, Y Yu - Smart Medicine, 2022 - Wiley Online Library
Biological organisms play important roles in human health, either in a commensal or
pathogenic manner. Harnessing inactivated organisms or living organisms is a promising …
pathogenic manner. Harnessing inactivated organisms or living organisms is a promising …
Clinical significance of microRNAs in hematologic malignancies and hematopoietic stem cell transplantation
A Sevcikova, I Fridrichova, N Nikolaieva, L Kalinkova… - Cancers, 2023 - mdpi.com
Simple Summary Dysregulated microRNA (miRNA) expression has been described in the
initiation and progression of a wide spectrum of hematologic malignancies. Moreover …
initiation and progression of a wide spectrum of hematologic malignancies. Moreover …
Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome
A Bettiol, M Becatti, E Silvestri… - Clinical & …, 2021 - academic.oup.com
Behçet's syndrome (BS) is a systemic vasculitis with several clinical manifestations.
Neutrophil hyperactivation mediates vascular BS pathogenesis, via both a massive reactive …
Neutrophil hyperactivation mediates vascular BS pathogenesis, via both a massive reactive …
GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol
DD Sukhtankar, JJ Fung, M Kim, T Cayton, V Chiou… - Plos one, 2023 - journals.plos.org
Autologous Stem Cell Transplant (ASCT) is increasingly used to treat hematological
malignancies. A key requisite for ASCT is mobilization of hematopoietic stem cells into …
malignancies. A key requisite for ASCT is mobilization of hematopoietic stem cells into …
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study
This retrospective study assessed the effectiveness of eltrombopag (EPAG), a
thrombopoietin receptor agonist, in the treatment of poor graft function (PGF) following an …
thrombopoietin receptor agonist, in the treatment of poor graft function (PGF) following an …
Decoding human hematopoietic stem cell self-renewal
Abstract Purpose of Review Hematopoietic stem cells (HSCs) maintain blood and immune
cell homeostasis by balancing quiescence, self-renewal, and differentiation. HSCs can be …
cell homeostasis by balancing quiescence, self-renewal, and differentiation. HSCs can be …
ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic …
Y Zhao, X Zheng, M Li, J Zhao, X Wang… - International …, 2023 - Elsevier
Th17/Treg equilibrium towards the pro-inflammatory Th17 side contributes greatly to the
rejection during allogeneic hematopoietic stem cell transplantation (allo-HSCT). Forkhead …
rejection during allogeneic hematopoietic stem cell transplantation (allo-HSCT). Forkhead …
TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses
R Harris, M Mammadli, S Hiner, L Suo, Q Yang… - Cancer Immunology …, 2023 - Springer
Cancer immunotherapy relies on improving T cell effector functions against malignancies,
but despite the identification of several key transcription factors (TFs), the biological …
but despite the identification of several key transcription factors (TFs), the biological …